Dr. Wan Azman Wan Ahmad and Dr. C. Michael Gibson Discuss: A Randomized Trial of Sirolimus-coated Versus Paclitaxel-coated Balloons in De Novo Coronary Lesions November 6, 2021 Disclosures: TBA
Dr. Roberto Galea and Dr. C. Michael Gibson Discuss: SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure November 6, 2021 Disclosures: TBA
Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss: TCT 2021 Daily Wrap-Up – November 5, 2021 November 5, 2021 Disclosures: TBA
Dr. Timothy Henry and Dr. C. Michael Gibson Discuss: SCAI SHOCK Update November 5, 2021 Disclosures: TBA
Dr. Dominick Angiolillo and Dr. C. Michael Gibson Discuss: Update on Vazalore: A Novel Aspirin Formulation November 5, 2021 Disclosures: TBA
Dr. Pieter C. Smits and Dr. C. Michael Gibson Discuss: MASTER-DAPT: A Randomized Trial of Abbreviated Antiplatelet Therapy – Outcomes in High Bleeding Risk Patients With High Thrombotic and Ischemic Risk November 5, 2021 Disclosures: TBA
Dr. Pavel Osmancik and Dr. C. Michael Gibson Discuss: PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation November 5, 2021 Disclosures: TBA
Dr. DJ Lakkireddy and Dr. C. Michael Gibson Discuss: AMULET IDE: One-Year Device Closure and Device-Related Thrombus Outcomes From a Randomized Trial of Amulet versus Watchman for Left Atrial Appendage Occlusion November 5, 2021 Disclosures: TBA
Dr. David J. Cohen and Dr. C. Michael Gibson Discuss: PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk November 5, 2021 Disclosures: TBD
Dr. Nicolas Van Mieghem and Dr. Yaz Dabboul Discuss: SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk November 5, 2021 Disclosures: TBD
